Risk Management

Basic Policy for Enterprise Risk Management (ERM) In order to ensu...

リード文

医療機関等との関係の透明性に関する指針 患者団体との関係の透明性に関する取り組み

リード文

ONO Pharmaceutical’s Compliance System Initiatives to Strengthen Comp...

Environmental Costs and Effects

Environmental Costs (Including Depreciation Costs) (Thousands o...

Declaration on Building Partnerships

We agree with the purport of the "Council on Promoting Partnership Buildi...

  Corporate Governance Corpo...

リード文

Traveling Science Workshop "Kusuri no Himitsu Manabu" Efforts for Canc...

Governance, Strategy, Risk and Opportunity Management, Indicators and Targets

Governance We recognize the preservation of the global environmen...

Pursuit of fair promotion activities

We define "Promotions” as "Providing and transmitting drug information to...

Top Message

Contributing to sustainable social development through business activit...

Cultivating a Quality Culture

For a pharmaceutical compan...

Improving the Capabilities of Our Talent

We believe it is important to improve the capabilities of all employe...

IR Activities

We disclose financial results and other timely disclosure information...

Basic Policy for Human Rights

Our Approach to Human Rights In all its business activities in and out...

Efforts made to promote employees’ health

Basic policy The ONO Group will strive to maintain and ...

リード文

For more than 300 years since our foundation, we have walked han...

アンカーリンク用

Our Stance on Sustainable Procurement Joining the PSCI (Pharmaceutica...

リード文

EHS Global Policy EHS Promotion System Building and Operating the E...

リード文

Dissemination of Medical Information Participating in Relay for Life...

リード文

Employees at each worksite actively participate in cleaning activities arou...

Progress

The total water withdrawal in FY2025 was 186.0 thousand m3, a reduction ...